Shorter Days, Signs of Fatigue: Trump Faces Realities of Aging in Office

President Trump has always used his stamina and energy as a political strength. But that image is getting harder for him to ...

Shorter days, signs of fatigue: Trump faces realities of ageing in office

US President Trump has always used his stamina and energy as a political strength. But that image is getting harder for him to sustain ...

Regeneron Pharmaceuticals, Inc.: Dupixent (dupilumab) Approved as the First Targeted Medicine in the European Union (EU) in Over a Decade for Chronic Spontaneous Urticaria (CSU)

Approval based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to placebo In the EU, there are approximately 270,000 adults and adolescents aged 12 years ...
Santé log

Dupixent® (dupilumab) Approved as the First Targeted Medicine in the European Union (EU) in Over a Decade for Chronic Spontaneous Urticaria (CSU)

The results from Studies A and B were published in The Journal of Allergy and Clinical Immunology.